Nanopore long-read RNA sequencing reveals functional alternative splicing variants in human vascular smooth muscle cells.
Hao WuYicheng LuZhenzhen DuanJingni WuMinghui LinYangjun WuSiyang HanTongqi LiYuqi FanXiaoyuan HuHongyan XiaoJiaxuan FengZhiqian LuDeping KongShengli LiPublished in: Communications biology (2023)
Vascular smooth muscle cells (VSMCs) are the major contributor to vascular repair and remodeling, which showed high level of phenotypic plasticity. Abnormalities in VSMC plasticity can lead to multiple cardiovascular diseases, wherein alternative splicing plays important roles. However, alternative splicing variants in VSMC plasticity are not fully understood. Here we systematically characterized the long-read transcriptome and their dysregulation in human aortic smooth muscle cells (HASMCs) by employing the Oxford Nanopore Technologies long-read RNA sequencing in HASMCs that are separately treated with platelet-derived growth factor, transforming growth factor, and hsa-miR-221-3P transfection. Our analysis reveals frequent alternative splicing events and thousands of unannotated transcripts generated from alternative splicing. HASMCs treated with different factors exhibit distinct transcriptional reprogramming modulated by alternative splicing. We also found that unannotated transcripts produce different open reading frames compared to the annotated transcripts. Finally, we experimentally validated the unannotated transcript derived from gene CISD1, namely CISD1-u, which plays a role in the phenotypic switch of HASMCs. Our study characterizes the phenotypic modulation of HASMCs from an insight of long-read transcriptome, which would promote the understanding and the manipulation of HASMC plasticity in cardiovascular diseases.
Keyphrases
- vascular smooth muscle cells
- single molecule
- single cell
- growth factor
- angiotensin ii
- transforming growth factor
- rna seq
- cardiovascular disease
- endothelial cells
- copy number
- genome wide
- gene expression
- epithelial mesenchymal transition
- induced pluripotent stem cells
- pluripotent stem cells
- left ventricular
- minimally invasive
- signaling pathway
- type diabetes
- newly diagnosed
- metabolic syndrome
- pulmonary artery
- coronary artery
- dna methylation
- heart failure
- working memory
- oxidative stress
- heat shock